← Back to Clinical Trials
Recruiting NCT06010199

NCT06010199 Risk Stratification Value of Biomarkers in Patients With Myocarditis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06010199
Status Recruiting
Phase
Sponsor First Affiliated Hospital Xi'an Jiaotong University
Condition Myocarditis
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2023-08-25
Primary Completion 2030-07-31

Eligibility & Interventions

Sex All sexes
Min Age 3 Years
Max Age 80 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2023-08-25 with a primary completion date of 2030-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.

Eligibility Criteria

Inclusion Criteria: * All patients should meet the diagnostic criteria for myocarditis * Patients who are regularly followed up at the corresponding cardiovascular center Exclusion Criteria: * Age \<3 years or \>80 years * Pregnant or lactating women * The patient refused to sign the informed consent and refused to participate in the study * None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent

Contact & Investigator

Central Contact

Guoliang Li

✉ liguoliang_med@163.com

📞 +8613759982523

Principal Investigator

Yang Yan

PRINCIPAL INVESTIGATOR

First Affiliated Hospital Xi'an Jiaotong University

Frequently Asked Questions

Who can join the NCT06010199 clinical trial?

This trial is open to participants of all sexes, aged 3 Years or older, up to 80 Years, studying Myocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06010199 currently recruiting?

Yes, NCT06010199 is actively recruiting participants. Contact the research team at liguoliang_med@163.com for enrollment information.

Where is the NCT06010199 trial being conducted?

This trial is being conducted at Xi'an, China.

Who is sponsoring the NCT06010199 clinical trial?

NCT06010199 is sponsored by First Affiliated Hospital Xi'an Jiaotong University. The principal investigator is Yang Yan at First Affiliated Hospital Xi'an Jiaotong University. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology